Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Disparities in the Management of Peritoneal Surface Malignancies. Surg Oncol Clin N Am 2022 Jan;31(1):29-41

Date

11/16/2021

Pubmed ID

34776062

DOI

10.1016/j.soc.2021.07.005

Scopus ID

2-s2.0-85117415093 (requires institutional sign-in at Scopus site)   4 Citations

Abstract

Peritoneal surface malignancies are a group of aggressive cancers involving the peritoneum. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy can improve outcomes and survival in select patients. Despite significant advancements in care, racial disparities in peritoneal malignancy outcomes persist and may have even worsened over time. Poor adherence to guideline-recommended therapy introduces wide variability in patient care and often results in fewer options and suboptimal treatment of vulnerable populations. This review explores biological, sociodemographic, and environmental factors that contribute to disparities in peritoneal malignancy outcomes.

Author List

Marulanda K, Maduekwe UN

Author

Ugwuji N. Maduekwe MD Associate Dean, Associate Professor in the Surgery department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Colorectal Neoplasms
Combined Modality Therapy
Humans
Hyperthermia, Induced
Peritoneal Neoplasms
Retrospective Studies